Recurrent Disease Active Not Recruiting Phase 1 Trials for Topotecan (DB01030)

IndicationStatusPhase
DBCOND0028541 (Recurrent Disease)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00588991Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative DisordersTreatment